17 May 2013

DEERFIELD, Ill – 17 May 2013 – Walgreen Co. (NYSE: WAG) (Nasdaq: WAG), the largest retail drugstore chain in the United States, and Alliance Boots GmbH, a leading international pharmacy-led health and beauty group, today announced that they have received the required regulatory clearances for their equity investment in AmerisourceBergen Corporation, one of North America’s largest pharmaceutical services companies.

The regulatory clearances permit both the purchase of up to 7 percent of the fully diluted equity of AmerisourceBergen in the open market, and the exercise of two warrants for 16 percent in the aggregate of the fully diluted equity of AmerisourceBergen in 2016 and 2017. The clearances permit the investment in AmerisourceBergen up to 25 percent in the aggregate, including the effect of any stock repurchases that AmerisourceBergen may engage in from time to time. Walgreens and Alliance Boots announced that they had been granted the right to purchase a minority equity position in AmerisourceBergen as part of a broader innovative long-term agreement on 19 March 2013.

About Walgreens

As the nation's largest drugstore chain with fiscal 2012 sales of $72 billion, Walgreens (www.walgreens.com) vision is to become the first choice for health and daily living for everyone in America and beyond. Each day, Walgreens provides more than 6 million customers the most convenient, multichannel access to consumer goods and services and trusted, cost-effective pharmacy, health and wellness services and advice in communities across America. Walgreens scope of pharmacy services includes retail, specialty, infusion, medical facility and mail service, along with respiratory services. These services improve health outcomes and lower costs for payers including employers, managed care organizations, health systems, pharmacy benefit managers and the public sector. The company operates 8,072 drugstores in all 50 states, the District of Columbia and Puerto Rico. Take Care Health Systems is a Walgreens subsidiary that is the largest and most comprehensive manager of worksite health and wellness centers and in-store convenient care clinics, with more than 700 locations throughout the country.

About Alliance Boots

Alliance Boots is a leading international, pharmacy-led health and beauty group delivering a range of products and services to customers. Working in close partnership with manufacturers and pharmacists, we are committed to improving health in the local communities we serve and helping our customers and patients to look and feel their best. Our focus is on growing our two core businesses: pharmacy-led health and beauty retailing and pharmaceutical wholesaling and distribution, while increasingly developing and internationalising our product brands.

Alliance Boots has a presence in more than 25* countries and employs over 108,000* people. Alliance Boots has pharmacy-led health and beauty retail businesses in nine* countries and operates more than 3,100* health and beauty retail stores, of which just over 3,000* have a pharmacy. In addition, Alliance Boots has around 605* optical practices, of which around 190* operate on a franchise basis, and around 390* hearingcare practices. Our pharmaceutical wholesale businesses deliver over 4.6 billion* units each year to more than 170,000* pharmacies, doctors, health centres and hospitals from over 370* distribution centres in 20* countries.

In June 2012, Alliance Boots announced that it had entered into a strategic partnership with Walgreen Co., the largest drugstore chain in the US, to create the first global pharmacy-led, health and wellbeing enterprise.

* Figures are approximations as at 31 March 2013 and include associates and joint ventures.

Contacts

Walgreens

Investor Relations:
Rick Hans / Ashish Kohli
+1 847 315 2385 / +1 847 315 3810

Media Relations:
Michael Polzin, +1 847 372 3502

Brunswick US (New York):
Steve Lipin / Radina Russell, +1 212 333 3810

Alliance Boots

Investor Relations:
Gerald Gradwell +44 (0)207 980 8527 (UK), +1 646 688 1336 (US)

Media Relations:
Yves Romestan / Laura Vergani / Katie Johnson, +44 (0)207 980 8585

RLM Finsbury UK (London):
James Murgatroyd / Katie Lang / Yim Wong, +44 (0)207 251 3801

Full press release as PDF - 17 May 2013

You must be logged in to view this item.

This area is reserved for members of the news media. If you qualify, please update your user profile and check the box marked "Check here to register as an accredited member of the news media". Please include any notes in the "Supporting information for media credentials" box. We will notify you of your status via e-mail in one business day.